Suchergebnisse - "Cervantes, A"

PubPharm (21)

1

Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer

enthalten in: British journal of cancer | 2016

von Elez, E. | Hendlisz, A. | Delaunoit, T. | +6

2

Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer

enthalten in: British journal of cancer | 2015

von Macarulla, T. | Cervantes, A. | Tabernero, J. | +10

3

Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2014

von Peeters, M. | Price, T. | Cervantes, A. | +14

ErratumIn: Ann Oncol. 2014 Mar;25(3):757

4

HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Sclafani, F. | Roy, A. | Cunningham, D. | +9

5

Early colon cancer : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2013

von Labianca, R. | Nordlinger, B. | Beretta, G. | +5

6

Role of Kras status in patients with metastatic colorectal cancer receiving first-line chemotherapy plus bevacizumab : a TTD group cooperative study

enthalten in: PloS one | 2012

von Díaz-Rubio, E. | Gómez-España, A. | Massutí, B. | +71

7

Cetuximab administered once every second week to patients with metastatic colorectal cancer : a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2010

von Tabernero, J. | Ciardiello, F. | Rivera, F. | +10

8

FOLFOX in patients with metastatic colorectal cancer and high alkaline phosphatase level : an exploratory cohort of the GERCOR OPTIMOX1 study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2009

von Chibaudel, B. | Tournigand, C. | Artru, P. | +12

9

Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2009

von Bidard, F. | Tournigand, C. | André, T. | +8

10

Guides for adjuvant treatment of colon cancer. TTD Group (Spanish Cooperative Group for Gastrointestinal Tumor Therapy)

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2006

von Aranda, E. | Abad, A. | Carrato, A. | +4